Assessment of Glucose Use
Weber W et al. J Clin Oncol 2003; 21: 2651-7.
responder
non-responder
●
FDG PET before
and after first cycle
of CT (n=57)
●
Metabolic response
= reduction of SUV
by more than 20%
●
SUV reduction
predictive for
therapy outcome